For the Inventor, By the Inventor

Enter assignee name

Rockville, MD, United States of America

Entremed, Inc.

USPTO Granted Patents = 28

Forward Citations = 860

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Shawn J Green (10 out of 15 patents)

Anthony Treston (7 out of 13 patents)

Gregory E Agoston (7 out of 9 patents)

4. Jamshed H Shah (7 out of 16 patents)

5. John W Holaday (5 out of 14 patents)

6. Adonia E Papathanassiu (5 out of 12 patents)

7. John W Madsen (5 out of 10 patents)

8. Theresa Marie LaVallee (4 out of 7 patents)

9. Glenn M Swartz, Jr (3 out of 7 patents)

10. Victor S Pribluda (3 out of 4 patents)

11. Peter M Meserol (3 out of 25 patents)

12. Stacy Plum (2 out of 6 patents)

13. Carl R Alving (2 out of 34 patents)

14. Lita Suwandi (2 out of 2 patents)

15. Kim Lee Sim (2 out of 13 patents)

28 patents: Sort by Forward Citations

1. 8399440 - Disease modifying anti-arthritic activity of 2-methoxyestradiol (2013-03-19),

2. 8158612 - Methods of treating disease states using antiangiogenic agents (2012-04-17),

3. 7498322 - Antiangiogenic agents (2009-03-03),

4. 7371741 - Estradiol derivatives and pharmaceutical compositions using same (2008-05-13),

5. 7235540 - Methods of using 2-methoxyestradiol of high purity (2007-06-26),

6. 7135581 - Antiangiogenic agents (2006-11-14),

7. 7087592 - Compositions comprising purified 2-methoxyestradiol and methods of producing same (2006-08-08),

8. 6995278 - Antiangiogenic agents (2006-02-07),

9. 6946439 - Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments (2005-09-20),

10. 6805865 - Compositions and methods for treating cancer and hyperproliferative disorders (2004-10-19),

11. 6734163 - Compositions and methods for inhibiting cellular proliferation (2004-05-11),

12. 6723536 - Method of producing and purifying angiostatin (2004-04-20),

13. 6605622 - Use of anti-estrogenic compounds as anti-fungal agents (2003-08-12),

14. 6593291 - Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease (2003-07-15),

15. 6544947 - Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using cancer markers (2003-04-08),

EntreMed, Inc. is a biopharmaceutical company that focuses on the research and development of innovative therapeutics for the treatment of cancer. With a dedication to advancing scientific and medical knowledge, EntreMed is committed to improving the lives of cancer patients through the discovery of novel drugs and therapies. Through a combination of cutting-edge technology and strategic partnerships, the company aims to bring breakthrough treatments to market and push the boundaries of oncology care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

28 Patents

#21 in Rockville, MD

#145 in Maryland

#11,610 in US

#22,565 in the World

Rockville, MD, United States of America

Entremed, Inc.

Forward Citations = 860

42 inventors:

Shawn J Green (10 out of 15 patents)

Anthony Treston (7 out of 13 patents)

Gregory E Agoston (7 out of 9 patents)

4. Jamshed H Shah (7 out of 16 patents)

5. John W Holaday (5 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…